HEART VALVES SANTA ANA MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE
|
Back to Search Results |
|
Model Number 305C |
Device Problem
Device Operates Differently Than Expected (2913)
|
Patient Problems
Aortic Regurgitation (1716); Aortic Valve Stenosis (1717)
|
Event Date 08/18/2016 |
Event Type
Injury
|
Manufacturer Narrative
|
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received information from this patient's physician that approximately three years, six months post-implant of this bioprosthetic aortic valve, transesophageal echocardiogram (tee) found "[p]rosthetic valve dysfunction with prosthetic valve stenosis with a 9 mmhg mean aortic outflow gradient and a calculated aortic valve area of 0.79 cm2.There is also moderate prosthetic valvular insufficiency." three years, seven months post implant of this device, this 23 mm valve was explanted and replaced with a 22 mm mechanical valve due to critical aortic stenosis.The patient presented symptomatically, and the physician reported that upon visualizing the valve in-situ, the valve was "extremely well incorporated.With no evidence whatsoever of perivalvular leak.The three leaflets were surprisingly thickened with inflammatory tissue and rendered nearly immobile.There was a possibility of some sense of regurgitation based on some mild retraction of each of the leaflets." no other adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Product analysis: upon receipt at medtronic¿s quality laboratory, the valve appeared distorted and oval shaped with the stent posts deflected.All leaflets were slightly stiff but flexible except where host tissue extends on the inflow and/or outflow.Tears on the tunica of the non-coronary and left cusps along the inflow margin of attachment appeared to have occurred during explant.All commissures appeared intact.Traces of pannus were observed along the inflow of the sewing ring.Pannus on the outflow was observed on the outflow rails of the right and non-coronary cusps, extending to all three stent posts, to the tops of non-coronary left and left right commissures.An unknown amount of pannus appeared to have been removed on the inflow and outflow during explant.Tan thrombotic appearing host tissue filled and stiffened all cusps on the outflow.Radiography showed no evidence of mineralization in the valve and/or host tissue.Conclusion: a review of the device history record (dhr) was performed for this valve.There were no correlations / issues identified in regard to manufacturing that could be related to this event.The device was manufactured per approved and released manufacturing processes and the device met all applicable manufacturing specifications prior to release for distribution.Distortion of the annular ring can restrict the leaflets from fully opening and/or cause misalignment of leaflets during valve closure.The impairment of leaflet mobility may have led to the thrombus formation on the outflow of the valve causing the stenosis and regurgitation.An unknown amount of pannus appeared to be removed on the inflow and outflow during explant.The pannus overgrowth on the inflow would have further impaired the leaflet mobility leading to stenosis.Immobile leaflets caused by thrombus are known risk and are addressed in the current risk management file.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|